STUDY OF THE PROBLEM OF ADVERSE EVENTS FROM CHEMOTHERAPY FOR TUBERCULOSIS IN CHILDREN AND ADOLESCENTS

Abstract

Tuberculosis (TB) remains a major global health problem, particularly among children and adolescents in high-burden countries. Although anti-tuberculosis chemotherapy is effective, it is frequently associated with adverse drug reactions (ADRs), which may compromise treatment adherence, therapeutic outcomes, and quality of life. This study aims to analyze the spectrum, frequency, risk factors, and clinical consequences of adverse events associated with anti-tuberculosis chemotherapy in children and adolescents